|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 424 for Tnfsf11

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.061s

Categories

Category: Publication
« show all
Type Details Score
Publication
33970941 | J:307332
First Author: MacLeod RS
Year: 2021
Journal: PLoS One
Title: Deletion of a putative promoter-proximal Tnfsf11 regulatory region in mice does not alter bone mass or Tnfsf11 expression in vivo.
Volume: 16
Issue: 5
Pages: e0250974
•
•
•
•
•
Publication
11804028 | J:268631
First Author: Odgren PR
Year: 2001
Journal: Int J Dev Biol
Title: Evidence that the rat osteopetrotic mutation toothless (tl) is not in the TNFSF11 (TRANCE, RANKL, ODF, OPGL) gene.
Volume: 45
Issue: 8
Pages: 853-9
•
•
•
•
•
Publication
26646205 | J:233619
First Author: Onal M
Year: 2016
Journal: Endocrinology
Title: Unique Distal Enhancers Linked to the Mouse Tnfsf11 Gene Direct Tissue-Specific and Inflammation-Induced Expression of RANKL.
Volume: 157
Issue: 2
Pages: 482-96
•
•
•
•
•
Publication
25431114 | J:233356
First Author: Onal M
Year: 2015
Journal: J Bone Miner Res
Title: A DNA segment spanning the mouse Tnfsf11 transcription unit and its upstream regulatory domain rescues the pleiotropic biologic phenotype of the RANKL null mouse.
Volume: 30
Issue: 5
Pages: 855-68
•
•
•
•
•
Publication
26332516 | J:278792
First Author: Onal M
Year: 2016
Journal: J Bone Miner Res
Title: Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.
Volume: 31
Issue: 2
Pages: 416-29
•
•
•
•
•
Publication
22207718 | J:333546
First Author: Onal M
Year: 2012
Journal: Mol Endocrinol
Title: The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice.
Volume: 26
Issue: 2
Pages: 341-8
•
•
•
•
•
Publication
17932217 | J:131132
First Author: Galli C
Year: 2008
Journal: Endocrinology
Title: Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass.
Volume: 149
Issue: 1
Pages: 146-53
•
•
•
•
•
Publication
16914731 | J:112132
First Author: Fu Q
Year: 2006
Journal: Mol Cell Biol
Title: Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer.
Volume: 26
Issue: 17
Pages: 6453-68
•
•
•
•
•
Publication
24877630 | J:214373
First Author: Ben-awadh AN
Year: 2014
Journal: Endocrinology
Title: Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.
Volume: 155
Issue: 8
Pages: 2797-809
•
•
•
•
•
Publication
37568820 | J:339083
 
First Author: Kolokotroni A
Year: 2023
Journal: Cancers (Basel)
Title: Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics.
Volume: 15
Issue: 15
•
•
•
•
•
Publication
24127173 | J:233240
First Author: Rinotas V
Year: 2014
Journal: J Bone Miner Res
Title: Novel genetic models of osteoporosis by overexpression of human RANKL in transgenic mice.
Volume: 29
Issue: 5
Pages: 1158-69
•
•
•
•
•
Publication
32870816 | J:301913
 
First Author: Kim HN
Year: 2020
Journal: JCI Insight
Title: Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence.
Volume: 5
Issue: 19
•
•
•
•
•
Publication
26393791 | J:243173
First Author: Xiong J
Year: 2015
Journal: PLoS One
Title: Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
Volume: 10
Issue: 9
Pages: e0138189
•
•
•
•
•
Publication
22778137 | J:188796
First Author: de Lau W
Year: 2012
Journal: Mol Cell Biol
Title: Peyer's patch M cells derived from Lgr5(+) stem cells require SpiB and are induced by RankL in cultured "miniguts".
Volume: 32
Issue: 18
Pages: 3639-47
•
•
•
•
•
Publication
30418981 | J:267704
First Author: Dogar AM
Year: 2018
Journal: PLoS One
Title: Short-lived AUF1 p42-binding mRNAs of RANKL and BCL6 have two distinct instability elements each.
Volume: 13
Issue: 11
Pages: e0206823
•
•
•
•
•
Publication
27311019 | J:249214
First Author: Kassem A
Year: 2016
Journal: PLoS One
Title: Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
Volume: 11
Issue: 6
Pages: e0156708
•
•
•
•
•
Publication
32792620 | J:294900
First Author: Koide M
Year: 2020
Journal: Sci Rep
Title: Sclerostin expression in trabecular bone is downregulated by osteoclasts.
Volume: 10
Issue: 1
Pages: 13751
•
•
•
•
•
Publication
9568710 | J:54447
First Author: Lacey DL
Year: 1998
Journal: Cell
Title: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Volume: 93
Issue: 2
Pages: 165-76
•
•
•
•
•
Publication
9520411 | J:46850
First Author: Yasuda H
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
Volume: 95
Issue: 7
Pages: 3597-602
•
•
•
•
•
Publication
10196481 | J:54689
First Author: Kodaira K
Year: 1999
Journal: Gene
Title: Cloning and characterization of the gene encoding mouse osteoclast differentiation factor.
Volume: 230
Issue: 1
Pages: 121-7
•
•
•
•
•
Publication
11250921 | J:68794
First Author: Ikeda T
Year: 2001
Journal: Endocrinology
Title: Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus.
Volume: 142
Issue: 4
Pages: 1419-26
•
•
•
•
•
Publication
11733492 | J:74744
First Author: Ito S
Year: 2002
Journal: J Biol Chem
Title: Crystal structure of the extracellular domain of mouse RANK ligand at 2.2-A resolution.
Volume: 277
Issue: 8
Pages: 6631-6
•
•
•
•
•
Publication
9950424 | J:52369
First Author: Kong YY
Year: 1999
Journal: Nature
Title: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
Volume: 397
Issue: 6717
Pages: 315-23
•
•
•
•
•
Publication
24014480 | J:233242
First Author: Fumoto T
Year: 2014
Journal: J Bone Miner Res
Title: Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis.
Volume: 29
Issue: 4
Pages: 830-42
•
•
•
•
•
Publication
21909103 | J:177558
First Author: Xiong J
Year: 2011
Journal: Nat Med
Title: Matrix-embedded cells control osteoclast formation.
Volume: 17
Issue: 10
Pages: 1235-41
•
•
•
•
•
Publication
17143276 | J:129593
First Author: Loser K
Year: 2006
Journal: Nat Med
Title: Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells.
Volume: 12
Issue: 12
Pages: 1372-9
•
•
•
•
•
Publication
12434161 | J:264357
First Author: Mizuno A
Year: 2002
Journal: J Bone Miner Metab
Title: Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis.
Volume: 20
Issue: 6
Pages: 337-44
•
•
•
•
•
Publication
20881963 | J:166077
First Author: Gonzalez-Suarez E
Year: 2010
Journal: Nature
Title: RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Volume: 468
Issue: 7320
Pages: 103-7
•
•
•
•
•
Publication
21909105 | J:177557
First Author: Nakashima T
Year: 2011
Journal: Nat Med
Title: Evidence for osteocyte regulation of bone homeostasis through RANKL expression.
Volume: 17
Issue: 10
Pages: 1231-4
•
•
•
•
•
Publication
33720039 | J:307029
 
First Author: Komatsu N
Year: 2021
Journal: J Clin Invest
Title: Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis.
Volume: 131
Issue: 6
•
•
•
•
•
Publication
37575184 | J:339330
First Author: Laster DJ
Year: 2023
Journal: iScience
Title: CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system.
Volume: 26
Issue: 8
Pages: 107428
•
•
•
•
•
Publication
24933342 | J:215499
 
First Author: Xiong J
Year: 2014
Journal: Bone
Title: Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.
Volume: 66
Pages: 146-54
•
•
•
•
•
Publication
11085748 | J:65888
First Author: Kim D
Year: 2000
Journal: J Exp Med
Title: Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE.
Volume: 192
Issue: 10
Pages: 1467-78
•
•
•
•
•
Publication
37298085 | J:336745
 
First Author: Fischer V
Year: 2023
Journal: Int J Mol Sci
Title: Role of Mast-Cell-Derived RANKL in Ovariectomy-Induced Bone Loss in Mice.
Volume: 24
Issue: 11
•
•
•
•
•
Publication
30046091 | J:266262
First Author: Xiong J
Year: 2018
Journal: Nat Commun
Title: Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss.
Volume: 9
Issue: 1
Pages: 2909
•
•
•
•
•
Publication
22068587 | J:179743
First Author: Douni E
Year: 2012
Journal: Hum Mol Genet
Title: A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF.
Volume: 21
Issue: 4
Pages: 784-98
•
•
•
•
•
Publication
30760811 | J:275543
First Author: Edamoto M
Year: 2019
Journal: Sci Rep
Title: Trans-pairing between osteoclasts and osteoblasts shapes the cranial base during development.
Volume: 9
Issue: 1
Pages: 1956
•
•
•
•
•
Publication
28821826 | J:256488
First Author: Shoji-Matsunaga A
Year: 2017
Journal: Sci Rep
Title: Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression.
Volume: 7
Issue: 1
Pages: 8753
•
•
•
•
•
Publication
10984520 | J:64737
First Author: Kim N
Year: 2000
Journal: Proc Natl Acad Sci U S A
Title: Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene.
Volume: 97
Issue: 20
Pages: 10905-10
•
•
•
•
•
Publication
11696430 | J:72393
First Author: Pettit AR
Year: 2001
Journal: Am J Pathol
Title: TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.
Volume: 159
Issue: 5
Pages: 1689-99
•
•
•
•
•
Publication
21854748 | J:176292
First Author: Knoop KA
Year: 2011
Journal: Am J Pathol
Title: Distinct developmental requirements for isolated lymphoid follicle formation in the small and large intestine: RANKL is essential only in the small intestine.
Volume: 179
Issue: 4
Pages: 1861-71
•
•
•
•
•
Publication
29292230 | J:266616
 
First Author: Huang H
Year: 2018
Journal: Bone
Title: Bone resorption deficiency affects tooth root development in RANKL mutant mice due to attenuated IGF-1 signaling in radicular odontoblasts.
Volume: 114
Pages: 161-171
•
•
•
•
•
Publication
22836362 | J:233265
First Author: Lo Iacono N
Year: 2012
Journal: J Bone Miner Res
Title: Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARO.
Volume: 27
Issue: 12
Pages: 2501-10
•
•
•
•
•
Publication
12952207 | J:103100
 
First Author: Odgren PR
Year: 2003
Journal: Connect Tissue Res
Title: The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue.
Volume: 44 Suppl 1
Pages: 264-71
•
•
•
•
•
Publication
28100034 | J:253557
First Author: Schena F
Year: 2017
Journal: Stem Cells
Title: Murine Rankl-/- Mesenchymal Stromal Cells Display an Osteogenic Differentiation Defect Improved by a RANKL-Expressing Lentiviral Vector.
Volume: 35
Issue: 5
Pages: 1365-1377
•
•
•
•
•
Publication
18606662 | J:137471
First Author: Barbaroux JB
Year: 2008
Journal: J Immunol
Title: Epidermal receptor activator of NF-kappaB ligand controls Langerhans cells numbers and proliferation.
Volume: 181
Issue: 2
Pages: 1103-8
•
•
•
•
•
Publication
31226438 | J:294963
 
First Author: Hai L
Year: 2019
Journal: Cytokine
Title: Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland.
Volume: 123
Pages: 154745
•
•
•
•
•
Publication
19298785 | J:149238
First Author: Fernandez-Valdivia R
Year: 2009
Journal: Dev Biol
Title: The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse.
Volume: 328
Issue: 1
Pages: 127-39
•
•
•
•
•
Publication
10574572 | J:60114
First Author: Kartsogiannis V
Year: 1999
Journal: Bone
Title: Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.
Volume: 25
Issue: 5
Pages: 525-34
•
•
•
•
•
Publication
10080918 | J:53970
First Author: Takahashi N
Year: 1999
Journal: Biochem Biophys Res Commun
Title: A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
Volume: 256
Issue: 3
Pages: 449-55
•
•
•
•
•
Publication
11827970 | J:76048
First Author: Tintut Y
Year: 2002
Journal: J Biol Chem
Title: 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.
Volume: 277
Issue: 16
Pages: 14221-6
•
•
•
•
•
Publication
14499638 | J:85641
First Author: Kim HH
Year: 2003
Journal: Exp Cell Res
Title: Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation.
Volume: 289
Issue: 2
Pages: 368-77
•
•
•
•
•
Publication
15145935 | J:91614
First Author: Seshasayee D
Year: 2004
Journal: J Biol Chem
Title: A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response.
Volume: 279
Issue: 29
Pages: 30202-9
•
•
•
•
•
Publication
15314684 | J:91970
First Author: Ikeda F
Year: 2004
Journal: J Clin Invest
Title: Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
Volume: 114
Issue: 4
Pages: 475-84
•
•
•
•
•
Publication
15731115 | J:98764
First Author: Bai XC
Year: 2005
Journal: J Biol Chem
Title: Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast.
Volume: 280
Issue: 17
Pages: 17497-506
•
•
•
•
•
Publication
16828054 | J:111295
First Author: Théoleyre S
Year: 2006
Journal: Biochem Biophys Res Commun
Title: Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
Volume: 347
Issue: 2
Pages: 460-7
•
•
•
•
•
Publication
16750945 | J:114086
First Author: Tat SK
Year: 2006
Journal: Bone
Title: OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation.
Volume: 39
Issue: 4
Pages: 706-15
•
•
•
•
•
Publication
15817678 | J:117323
First Author: Lee NK
Year: 2005
Journal: Blood
Title: A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.
Volume: 106
Issue: 3
Pages: 852-9
•
•
•
•
•
Publication
19008464 | J:143084
First Author: Cheng T
Year: 2009
Journal: Mol Endocrinol
Title: Mutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activation.
Volume: 23
Issue: 1
Pages: 35-46
•
•
•
•
•
Publication
21078845 | J:168604
First Author: Lin X
Year: 2011
Journal: Infect Immun
Title: Antibody to receptor activator of NF-κB ligand ameliorates T cell-mediated periodontal bone resorption.
Volume: 79
Issue: 2
Pages: 911-7
•
•
•
•
•
Publication
21561598 | J:173248
First Author: Yamada T
Year: 2011
Journal: Am J Pathol
Title: RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression.
Volume: 178
Issue: 6
Pages: 2845-56
•
•
•
•
•
Publication
21835177 | J:175237
First Author: Ang ES
Year: 2011
Journal: FEBS Lett
Title: Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation.
Volume: 585
Issue: 17
Pages: 2755-62
•
•
•
•
•
Publication
24752296 | J:211309
First Author: Khan IS
Year: 2014
Journal: J Exp Med
Title: Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance.
Volume: 211
Issue: 5
Pages: 761-8
•
•
•
•
•
Publication
25138550 | J:215378
 
First Author: Shi C
Year: 2014
Journal: Bone
Title: MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
Volume: 68
Pages: 67-75
•
•
•
•
•
Publication
26571489 | J:244744
First Author: Liu W
Year: 2015
Journal: PLoS One
Title: Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway.
Volume: 10
Issue: 11
Pages: e0142519
•
•
•
•
•
Publication
28739641 | J:253422
First Author: Chen X
Year: 2017
Journal: FASEB J
Title: Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
Volume: 31
Issue: 11
Pages: 4855-4865
•
•
•
•
•
Publication
30185903 | J:265294
First Author: Ikebuchi Y
Year: 2018
Journal: Nature
Title: Coupling of bone resorption and formation by RANKL reverse signalling.
Volume: 561
Issue: 7722
Pages: 195-200
•
•
•
•
•
Publication
31208720 | J:290898
First Author: Ock S
Year: 2019
Journal: Biochem Biophys Res Commun
Title: RANKL blockade suppresses pathological angiogenesis and vascular leakage in ischemic retinopathy.
Volume: 516
Issue: 2
Pages: 350-356
•
•
•
•
•
Publication
32197293 | J:298446
 
First Author: Kamiya Y
Year: 2020
Journal: Int J Mol Sci
Title: IL-35 and RANKL Synergistically Induce Osteoclastogenesis in RAW264 Mouse Monocytic Cells.
Volume: 21
Issue: 6
•
•
•
•
•
Publication
31964464 | J:297916
First Author: Ding N
Year: 2020
Journal: BMB Rep
Title: Physalin D inhibits RANKL-induced osteoclastogenesis and bone loss via regulating calcium signaling.
Volume: 53
Issue: 3
Pages: 154-159
•
•
•
•
•
Publication
15750601 | J:97515
First Author: Wada T
Year: 2005
Journal: Nat Med
Title: The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.
Volume: 11
Issue: 4
Pages: 394-9
•
•
•
•
•
Publication
19336404 | J:150506
First Author: Kim T
Year: 2009
Journal: J Biol Chem
Title: Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation.
Volume: 284
Issue: 22
Pages: 15308-16
•
•
•
•
•
Publication
33893301 | J:306426
First Author: Blomberg Jensen M
Year: 2021
Journal: Nat Commun
Title: RANKL regulates male reproductive function.
Volume: 12
Issue: 1
Pages: 2450
•
•
•
•
•
Publication
20059964 | J:157871
First Author: Subramaniam M
Year: 2010
Journal: Biochem Biophys Res Commun
Title: TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts.
Volume: 392
Issue: 1
Pages: 72-6
•
•
•
•
•
Publication
17363454 | J:122330
First Author: Hiramatsu K
Year: 2007
Journal: Endocrinology
Title: Overexpression of gamma-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis.
Volume: 148
Issue: 6
Pages: 2708-15
•
•
•
•
•
Publication
14634009 | J:88473
First Author: Niida S
Year: 2004
Journal: J Biol Chem
Title: Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor.
Volume: 279
Issue: 7
Pages: 5752-6
•
•
•
•
•
Publication
18952894 | J:146094
First Author: Hikata T
Year: 2009
Journal: Blood
Title: PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.
Volume: 113
Issue: 10
Pages: 2202-12
•
•
•
•
•
Publication
20357249 | J:160458
First Author: Ha J
Year: 2010
Journal: J Immunol
Title: CXC chemokine ligand 2 induced by receptor activator of NF-kappa B ligand enhances osteoclastogenesis.
Volume: 184
Issue: 9
Pages: 4717-24
•
•
•
•
•
Publication
23142594 | J:193746
First Author: Li C
Year: 2012
Journal: Biochem Biophys Res Commun
Title: RANKL downregulates cell surface CXCR6 expression through JAK2/STAT3 signaling pathway during osteoclastogenesis.
Volume: 429
Issue: 3-4
Pages: 156-62
•
•
•
•
•
Publication
25955862 | J:222956
 
First Author: Vinik Y
Year: 2015
Journal: Elife
Title: The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.
Volume: 4
Pages: e05914
•
•
•
•
•
Publication
22899855 | J:318092
First Author: Griffin AC 3rd
Year: 2012
Journal: Mol Endocrinol
Title: MKP-1 is essential for canonical vitamin D-induced signaling through nuclear import and regulates RANKL expression and function.
Volume: 26
Issue: 10
Pages: 1682-93
•
•
•
•
•
Publication
9367155 | J:44239
First Author: Anderson DM
Year: 1997
Journal: Nature
Title: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Volume: 390
Issue: 6656
Pages: 175-9
•
•
•
•
•
Publication
10224132 | J:54896
First Author: Lum L
Year: 1999
Journal: J Biol Chem
Title: Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival.
Volume: 274
Issue: 19
Pages: 13613-8
•
•
•
•
•
Publication
10952716 | J:64174
First Author: Min H
Year: 2000
Journal: J Exp Med
Title: Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.
Volume: 192
Issue: 4
Pages: 463-74
•
•
•
•
•
Publication
21059944 | J:245342
First Author: Ta HM
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis.
Volume: 107
Issue: 47
Pages: 20281-6
•
•
•
•
•
Publication
17881498 | J:128364
First Author: Yang S
Year: 2007
Journal: J Cell Sci
Title: Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation.
Volume: 120
Issue: Pt 19
Pages: 3362-71
•
•
•
•
•
Publication
32600615 | J:305051
First Author: Ohno T
Year: 2020
Journal: Biochem Biophys Res Commun
Title: TSLP is a negative regulator of RANKL-induced osteoclastogenesis.
Volume: 530
Issue: 3
Pages: 508-512
•
•
•
•
•
Publication
28744019 | J:252360
First Author: Streicher C
Year: 2017
Journal: Sci Rep
Title: Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells.
Volume: 7
Issue: 1
Pages: 6460
•
•
•
•
•
Publication
33159483 | J:302269
First Author: Ma J
Year: 2021
Journal: Cell Prolif
Title: The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Volume: 54
Issue: 1
Pages: e12955
•
•
•
•
•
Publication
21464945 | J:171666
First Author: Won HY
Year: 2011
Journal: PLoS One
Title: Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in TallyHo/JngJ mice.
Volume: 6
Issue: 3
Pages: e18168
•
•
•
•
•
Publication
32854285 | J:304157
 
First Author: Jansen IDC
Year: 2020
Journal: Int J Mol Sci
Title: LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro.
Volume: 21
Issue: 17
•
•
•
•
•
Publication
22125315 | J:182803
First Author: Aliprantis AO
Year: 2012
Journal: FASEB J
Title: Transient muscle paralysis degrades bone via rapid osteoclastogenesis.
Volume: 26
Issue: 3
Pages: 1110-8
•
•
•
•
•
Publication
21947283 | J:178878
First Author: Kim NS
Year: 2011
Journal: Mol Cell Biol
Title: Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling.
Volume: 31
Issue: 23
Pages: 4775-88
•
•
•
•
•
Publication
17038532 | J:144460
First Author: Min JK
Year: 2007
Journal: Blood
Title: Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice.
Volume: 109
Issue: 4
Pages: 1495-502
•
•
•
•
•
Publication
24161214 | J:337166
 
First Author: Guerra-Menéndez L
Year: 2013
Journal: J Transl Med
Title: IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand.
Volume: 11
Pages: 271
•
•
•
•
•
Publication
37338990 | J:339974
 
First Author: Miyagawa K
Year: 2023
Journal: JCI Insight
Title: Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation.
Volume: 8
Issue: 14
•
•
•
•
•
Publication
26670608 | J:230922
First Author: Takegahara N
Year: 2016
Journal: J Biol Chem
Title: Involvement of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts.
Volume: 291
Issue: 7
Pages: 3439-54
•
•
•
•
•
Publication
26061636 | J:233812
First Author: Szwarc MM
Year: 2015
Journal: PLoS One
Title: Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.
Volume: 10
Issue: 6
Pages: e0128467
•
•
•
•
•
Publication
22782898 | J:190415
First Author: Onal M
Year: 2012
Journal: J Biol Chem
Title: Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss.
Volume: 287
Issue: 35
Pages: 29851-60
•
•
•
•
•
Publication
34594237 | J:312667
 
First Author: Settem RP
Year: 2021
Journal: Front Physiol
Title: B-Cell RANKL Contributes to Pathogen-Induced Alveolar Bone Loss in an Experimental Periodontitis Mouse Model.
Volume: 12
Pages: 722859
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom